跳至主要内容
临床试验/DRKS00032503
DRKS00032503尚未招募Unknown

Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients – a randomized rater-blinded trial - P4D-2A

Medizinische Hochschule Hannover0 个研究点目标入组 256 人开始时间: 2023年8月17日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
256

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Severity of symptoms: Severe (HDRS-24 = 25)
  • - Change of therapy / alteration of medication therapy
  • - First depressive episode before the age of 50
  • - Signed informed consent
  • - Capacity to provide consent

排除标准

  • - Acute suicidality
  • - Involuntary placement according to state law (e.g., §16/17 Nds. PsychKG)
  • - Persistent depressive disorder (PDD)
  • - Following diagnoses in medical history: Dementia, schizophrenia, schizoaffective disorder, bipolar disorder, substance dependence with current necessary detoxification
  • - Simultaneous participation in other clinical studies not conducted within the scope of the P4D project

研究者

发起方
Medizinische Hochschule Hannover

相似试验